Vancomycin Global Market Report 2025

Description

Vancomycin is a powerful antibiotic used against bacterial infections, particularly Gram-positive strains resistant to other antibiotics. It operates by impeding bacterial cell wall synthesis, halting bacterial growth.

The primary forms of vancomycin are injectable solutions and powder for injection. Injectable solutions are pre-mixed liquids for intravenous use, ensuring swift and effective treatment of severe infections by directly delivering the drug into the bloodstream. The routes of administration include intravenous and oral methods, targeting applications such as sepsis, lung and skin infections, colitis, and for preventative measures against infections.

The vancomycin market research report is one of a series of new reports from The Business Research Company that provides vancomycin market statistics, including vancomycin industry global market size, regional shares, competitors with a vancomycin market share, detailed vancomycin market segments, market trends, and opportunities, and any further data you may need to thrive in the vancomycin industry. This vancomycin research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vancomycin market size has grown rapidly in recent years. It will grow from $0.82 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, increasing global travel and trade, growing use in hospital settings, and increased healthcare spending.

The vancomycin market size is expected to see rapid growth in the next few years. It will grow to $1.4 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to the increasing emergence of novel pathogens, increasing demand for rapid and on-site testing solutions, growing emphasis on early detection systems, rising demand for vancomycin, and increased R&D activities. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies and integration of AI and machine learning algorithms into diagnostic platforms.

The vancomycin market is poised for growth due to the increasing prevalence of infectious diseases caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. Factors contributing to this rise include antimicrobial resistance, climate change, and population growth. Vancomycin plays a critical role in treating severe gram-positive bacterial infections, particularly resistant strains, following clinical guidelines and antimicrobial stewardship for optimal patient outcomes. For example, the global HIV/AIDS population exceeded 39 million in 2023, showing a 3.17% increase from 2020, as reported by UNAIDS. Additionally, tuberculosis (TB) cases in the US rose by 5.9% from 2021 to 2022, according to the Centers for Disease Control and Prevention.

Key players in the vancomycin market are actively developing innovative products such as anti-infective and anti-hypotensive medications to maintain their market position. Anti-infective medications target infections caused by various microorganisms, while anti-hypotensive medications are used to raise blood pressure in individuals with hypotension. For instance, Baxter International Inc. launched five injectable products in the US in April 2024, addressing anesthesia, pain management, and specialized therapies needs, demonstrating a commitment to improving patient outcomes.

In January 2023, Fairlong Capital LLC acquired DoseMeRx from Tabula Rasa HealthCare Group Inc., expanding its presence in healthcare technology with DoseMeRx's clinical decision support software for personalized dosing. DoseMeRx assists pharmacists and physicians in accurately tailoring doses of high-risk parenteral medications to individual patient needs.

Major companies operating in the vancomycin market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics Pvt. Ltd., DiaSorin SpA, Myriad Genetics Inc., Seegene Inc., ANI Pharmaceuticals Inc., Alvogen Inc., Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

North America was the largest region in the vancomycin market in 2024. The regions covered in the vancomycin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vancomycin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vancomycin market consists of sales of intravenous (IV) formulations, compounded products, diagnostic kits and monitoring devices, therapeutic drug monitoring (TDM) kits, and diagnostic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vancomycin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vancomycin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vancomycin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vancomycin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Injectable Solution; Powder For Injection
2) By Route Of Administration: Intravenous; Oral
3) By Application: Sepsis; Lung Infection; Skin Soft Tissue Infection; Colitis And Intestinal Inflammation; To Prevent Infection
Subsegments:
1) By Injectable Solution: Pre-Mixed Injectable Solution; Ready-To-Use Injectable Solution; Concentrated Injectable Solution
2) By Powder For Injection: Vancomycin Powder For Intravenous Use; Vancomycin Powder For Reconstitution
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Becton Dickinson And Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31464

1. Executive Summary

2. Vancomycin Market Characteristics

3. Vancomycin Market Trends And Strategies

4. Vancomycin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Vancomycin Growth Analysis And Strategic Analysis Framework

5.1. Global Vancomycin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vancomycin Market Growth Rate Analysis
5.4. Global Vancomycin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vancomycin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vancomycin Total Addressable Market (TAM)

6. Vancomycin Market Segmentation

6.1. Global Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Solution
Powder For Injection
6.2. Global Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Oral
6.3. Global Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sepsis
Lung Infection
Skin Soft Tissue Infection
Colitis And Intestinal Inflammation
To Prevent Infection
6.4. Global Vancomycin Market, Sub-Segmentation Of Injectable Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-Mixed Injectable Solution
Ready-To-Use Injectable Solution
Concentrated Injectable Solution
6.5. Global Vancomycin Market, Sub-Segmentation Of Powder For Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vancomycin Powder For Intravenous Use
Vancomycin Powder For Reconstitution

7. Vancomycin Market Regional And Country Analysis

7.1. Global Vancomycin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vancomycin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vancomycin Market

8.1. Asia-Pacific Vancomycin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vancomycin Market

9.1. China Vancomycin Market Overview
9.2. China Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vancomycin Market

10.1. India Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vancomycin Market

11.1. Japan Vancomycin Market Overview
11.2. Japan Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vancomycin Market

12.1. Australia Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vancomycin Market

13.1. Indonesia Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vancomycin Market

14.1. South Korea Vancomycin Market Overview
14.2. South Korea Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vancomycin Market

15.1. Western Europe Vancomycin Market Overview
15.2. Western Europe Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vancomycin Market

16.1. UK Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vancomycin Market

17.1. Germany Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vancomycin Market

18.1. France Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vancomycin Market

19.1. Italy Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vancomycin Market

20.1. Spain Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vancomycin Market

21.1. Eastern Europe Vancomycin Market Overview
21.2. Eastern Europe Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vancomycin Market

22.1. Russia Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vancomycin Market

23.1. North America Vancomycin Market Overview
23.2. North America Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vancomycin Market

24.1. USA Vancomycin Market Overview
24.2. USA Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vancomycin Market

25.1. Canada Vancomycin Market Overview
25.2. Canada Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vancomycin Market

26.1. South America Vancomycin Market Overview
26.2. South America Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vancomycin Market

27.1. Brazil Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vancomycin Market

28.1. Middle East Vancomycin Market Overview
28.2. Middle East Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vancomycin Market

29.1. Africa Vancomycin Market Overview
29.2. Africa Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vancomycin Market Competitive Landscape And Company Profiles

30.1. Vancomycin Market Competitive Landscape
30.2. Vancomycin Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

31. Vancomycin Market Other Major And Innovative Companies

31.1. Quest Diagnostics Incorporated
31.2. Hologic Inc.
31.3. bioMerieux SA
31.4. Sysmex Corporation
31.5. Bio-Rad Laboratories Inc.
31.6. QIAGEN N.V.
31.7. Ortho Clinical Diagnostics Pvt. Ltd.
31.8. DiaSorin SpA
31.9. Myriad Genetics Inc.
31.10. Seegene Inc.
31.11. ANI Pharmaceuticals Inc.
31.12. Alvogen Inc.
31.13. Biodesix Inc.
31.14. Helix OpCo LLC
31.15. Inovio Pharmaceuticals Inc.

32. Global Vancomycin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vancomycin Market

34. Recent Developments In The Vancomycin Market

35. Vancomycin Market High Potential Countries, Segments and Strategies

35.1 Vancomycin Market In 2029 - Countries Offering Most New Opportunities
35.2 Vancomycin Market In 2029 - Segments Offering Most New Opportunities
35.3 Vancomycin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer